Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 15:390:112628.
doi: 10.1016/j.bbr.2020.112628. Epub 2020 May 11.

Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression?

Chadi G Abdallah  1 , John H Krystal  2
Affiliations
Review

Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression?

Chadi G Abdallah et al. Behav Brain Res. .

Abstract

Depression is a leading cause of disability, with often chronic course of illness and high treatment resistance in a large proportion of patients. In the current short perspective paper, we present evidence supporting the presence of synaptic-based chronic stress pathology (CSP) in depression and across a number of psychiatric disorders. We summarize the synaptic connectivity model of CSP, and briefly review related preclinical and clinical evidence, while providing appropriate references for more comprehensive reviews and alternative models. We then underscore some gaps in the literature and provide various tips for future directions.

Keywords: Antidepressants; Depression; Ketamine; Rapamycin; Relapse prevention; Synaptic plasticity.

PubMed Disclaimer

References

    1. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR, Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis, Lancet 391(10128) (2018) 1357–1366. - PMC - PubMed
    1. Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, Cowen PJ, Geddes JR, Stein DJ, Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis, Psychol Med (2017) 1–10. - PubMed
    1. Helfer B, Samara MT, Huhn M, Klupp E, Leucht C, Zhu Y, Engel RR, Leucht S, Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis, Am J Psychiatry 173(9) (2016) 876–86. - PubMed
    1. Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS, Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial, JAMA psychiatry 71(6) (2014) 681–8. - PubMed
    1. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ, Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial, Am J Psychiatry 170(10) (2013) 1134–42. - PMC - PubMed

Publication types

MeSH terms